三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
ITT人群PFS亚组分析(IRC评估)
ITT人群PFS亚组分析(IRC评估)
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:272KB
图片尺寸:1210*843
同报告图片
/
4
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
所属报告:
中国生物制药-港股公司研究报告-Pharma转型成效显著自主创新与开放合作并重前行-250208(42页).pdf
打包全文图表
相关数据
多纳非尼ZGDD3临床研究无进展生存期数据(ITT集)
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
收藏
行业数据
2026-06-26
原图定位
查看详情
ZG005治疗宫颈癌患者的无进展生存期(IRC评估)
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
收藏
行业数据
2026-06-26
原图定位
查看详情
多纳非尼ZGDD3临床研究有效性数据(ITT集)
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
收藏
行业数据
2026-06-26
原图定位
查看详情
依沃西为全球首个在三期临床中头对头击败K药的新药,PFS强阳性(HR=0.51)
收藏
行业数据
2026-03-31
原图定位
查看详情
HARMONi-6试验主要终点:依沃西+化疗较对照臂PFS提升4.2个月(HR=0.60)
收藏
行业数据
2026-03-31
原图定位
查看详情
CARTITUDE-4 TME: Patients With Shorter PFS (≤18M) and Patients With More pLOT had a More Suppressive TME
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
收藏
行业数据
2026-03-11
原图定位
查看详情
CARTITUDE-4: PFS and OS in Patients With Standard-Risk Cytogenetics (As-Treated)
fCDnu4TliKsgfCAzMOS4quaciOaXoOi/m+WxleeUn+WtmOeOh++8iFBGUywgJe+8iSB8IDMw5Liq5pyI5oC755Sf5a2Y546H77yIT1MsICXvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCBDQVJUSVRVREUgLSA0IOagh+WHhumjjumZqSB8IDgwLjUgfCA4Ny4zIHwKfCBDQVJUSVRVREUgLSA0IOagh+WHhumjjumZqSArIGdhaW4vYW1wKDFxKSB8IDcxLjcgfCA4Ni4xIHwKCui1hOaWmeadpea6kO+8mlBBUlRJVFVERSAtIDQg56CU56m277yI5qCH5YeG6aOO6Zmp57uG6IOe6YGX5Lyg5a2m5oKj6ICFIEFzIC0gVHJlYXRlZCDliIbmnpDvvInmlbDmja4=
收藏
行业数据
2026-03-11
原图定位
查看详情
Figure 3: PFS (A) and OS (B)
fCDmjIfmoIcgICAgICAgfCAzNuS4quaciOeOhyB8IDk1JSDnva7kv6HljLrpl7QgfAp8LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS18CnwgUEZTICAgICAgICB8IDkzLjglICAgIHwgNjMuMuKAkzk5LjEgICAgfAp8IE9TICAgICAgICAgfCA5My44JSAgICB8IDYzLjLigJM5OS4xICAgIHwKCui1hOaWmeadpea6kO+8muWbvueJh+S4reKAnFJlc3VsdHPigJ3mnb/lnZflj4pGaWd1cmUgM++8iFBGUyAoQSkg5ZKMIE9TIChCKe+8ieWGheWuueOAgg==
收藏
行业数据
2026-03-11
原图定位
查看详情
CARTITUDE-4: Overall MRD Negativity in Subgroups (ITT)
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
收藏
行业数据
2026-03-11
原图定位
查看详情
CARTITUDE-4: Secondary Endpoint (ITT) – Response
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
收藏
行业数据
2026-03-11
原图定位
查看详情
RBANS总分变化比较:完成者vS.ITT-MAR(p=0.032VS.0.012;调整β=4.75VS.4.67)
fCDliIbmnpDnsbvlnosgICAgICAgICB8IE4gICB8IEVHNTAx5Z2H5YC8zpQgfCDlronmhbDliYLlnYflgLzOlCB8CnwtLS0tLS0tLS0tLS0tLS0tLS18LS0tLS18LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS18Cnwg5a6M5oiQ6ICF5YiG5p6QICAgICAgIHwgNDMgIHwgMTAuNSAgICAgICB8IDQuMyAgICAgICAgIHwKfCBJVFQgLSBNQVLliIbmnpAgICAgfCA1NiAgfCAxMC40ICAgICAgIHwgNC40ICAgICAgICAgfAoK5pWw5o2u5p2l5rqQ77ya5Z+D5qC85p6X5Yy76I2v5L6b5Zu+
收藏
行业数据
2025-12-30
原图定位
查看详情
T-DXd对HER2-lowBC的全人群PFS
fCDpobnnm64gICAgICAgICAgICAgICAgfCBULURYZCAgICAgICB8IFRQQyAgICAgICAgIHwKfC0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS18Cnwg5Lit5L2N5peg6L+b5bGV55Sf5a2Y5pyfKG1vKSB8IDkuOSAgICAgICAgIHwgNS4xICAgICAgICAgfAp8IOmjjumZqeavlChIYXphcmQgUmF0aW8pIHwgMC41MCAgICAgICAgfCAtICAgICAgICAgICB8CnwgOTUl572u5L+h5Yy66Ze0KDk1JSBDSSkgIHwgMC40MCAtIDAuNjMgfCAtICAgICAgICAgICB8CnwgUOWAvCAgICAgICAgICAgICAgICAgfCA8IDAuMDAwMSAgICB8IC0gICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muesrOS4gOS4ieWFse+8jEFTQ08gMjAyMu+8jOeIseW7uuivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-11-24
原图定位
查看详情
Ivonescimab国内临床,PFS显著优于K药
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
收藏
行业数据
2025-10-24
原图定位
查看详情
izabren展现EGFRmNSCLC二线治疗历史最长PFS(单位:月)
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
收藏
行业数据
2025-09-16
原图定位
查看详情
Vepdegestrantvs氟维司群在HR+/HER2-BC(全人群)的PFS数据
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
收藏
行业数据
2025-08-08
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
安全性方面表现良好:依奉阿克和克唑替尼≥3级治疗相关不良事件(TRAE)发生率为51.9% vs 40.6%,因 TRAE 导致的停药率分别为 4.6%和 3.0%,依奉阿克组因 TRAE 用药暂停、终止治疗或死亡的发生率较低。且依奉阿克组大多为 1-2 级 AEs,最常见的 TRAEs 包括腹泻、呕吐、ALT 升高、恶心和 AST 升高等,血液相关毒性较低。
行业数据
原图定位
当前图表所属:
中国生物制药-港股公司研究报告-Pharma转型成效显著自主创新与开放合作并重前行-250208(42页).pdf
中国生物制药的生物类似物管线进展
中国生物制药MASH领域布局
天晴甘美上市以来销售额/百万美元,截止至2019年
全球PDE3/4抑制剂研发进展
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》